A

M

ALCANTARA , Marion

Last name: ALCANTARA

First name: Marion

September 19, 2024 (v1)

Journal article

Metadata-only

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients

Alcantara, Marion Chevrier, Marion Jardin, Fabrice

Background: Results of conventional induction chemotherapies in primary central nervous system lymphoma (PCNSL) need to be improved. Ibrutinib, a BTK inhibitor, and lenalidomide, an immunomodulatory drug, have shown promising results at relapse, supporting to further assess their individual use in combination with high-dose methotrexate-based...

Uploaded on: October 4, 2024
June 2, 2023 (v1)

Conference paper

Metadata-only

Final analysis of the phase IB part of the LOC-R01 trial, a non-comparative randomized phase IB/II study of escalating doses of lenalidomide and ibrutinib in association with R-MPV for patients with a newly diagnosed primary central nervous system lymphoma (PCNSL)

Alcantara, Marion Chevrier, Marion Jardin, Fabrice

International audience

Uploaded on: October 11, 2023